(Q22252558)

silent myocardial infarction

inferred from title

1 reference

3

Yves Cottin

Yves

Cottin

1 reference

PubMed

PubMed publication ID

7 February 2023

Paul Valensi

1

Paul

Valensi

1 reference

PubMed

PubMed publication ID

21497307

7 February 2023

Luc Lorgis

series ordinal

2

author given names

Luc

author last names

Lorgis

1 reference

PubMed

PubMed publication ID

21497307

Archives of Cardiovascular Diseases

7 February 2023

language of work or name

English

0 references

publication date

March 2011

0 references

published in

0 references

volume

104

0 references

issue

3

0 references

page(s)

178-188

0 references

cites work

Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community population

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

The natural history of prevalent ischaemic heart disease in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Incidence, precursors and prognosis of unrecognized myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Silent myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

The electrocardiogram in population studies. A classification system

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...]

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

The incidence of unrecognized myocardial infarction in women with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021

Unrecognized myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.ACVD.2010.11.013

7 January 2021